menu ☰
menu ˟

Additional milestone payment made from Valeant to EyeGate for EGP-437

12 Jan 2017
EyeGate Pharmaceuticals has received an additional milestone payment from Valeant Pharmaceuticals for worldwide commercial and manufacturing rights to its EyeGate II delivery system and EGP-437 combination product for uveitis, according to an EyeGate...

Click here to view the full article which appeared in Optometry

Please note

The news articles accessible on the Health Well website have been compiled from various sources that are not controlled by the Institute of Public Health in Ireland (IPH). IPH is therefore not responsible for the content of external websites and the inclusion of a link to an external website from the Health Well should not be understood to be an endorsement of that website.